Manuka Honey in Preventing Esophagitis-Related Pain in Patients Receiving Chemotherapy and Radiation Therapy For Lung Cancer

Bio2RDF identifier

NCT01262560

http://www.w3.org/2001/XMLSchema#string

Bio2RDF namespace

clinicaltrials

http://www.w3.org/2001/XMLSchema#string

Bio2RDF uri

http://bio2rdf.org/clinicaltrials:NCT01262560

http://www.w3.org/2001/XMLSchema#string

identifiers.org URI

NCT01262560

actual enrollment [clinicaltrials_vocabulary:actual-enrollment]

163

http://www.w3.org/2001/XMLSchema#integer

arm group [clinicaltrials_vocabulary:arm-group]

NCT01262560 arm group 222eb891ae81c080368701003e934e41 [clinicaltrials_resource:NCT01262560/arm-group/222eb891ae81c080368701003e934e41]

NCT01262560 arm group 298a4987c1fd199176e2d4e295e78325 [clinicaltrials_resource:NCT01262560/arm-group/298a4987c1fd199176e2d4e295e78325]

NCT01262560 arm group 6811badac0818e6e34d815273e6f2fd7 [clinicaltrials_resource:NCT01262560/arm-group/6811badac0818e6e34d815273e6f2fd7]

authority [clinicaltrials_vocabulary:authority]

clinicaltrials_resource:d942c8692d257084abf3ac87279faff6

brief summary [clinicaltrials_vocabulary:brief-summary]

RATIONALE: Manuka honey ...... tion therapy for lung cancer.

http://www.w3.org/2001/XMLSchema#string

brief title [clinicaltrials_vocabulary:brief-title]

Manuka Honey in Preventing Eso ...... iation Therapy For Lung Cancer

http://www.w3.org/2001/XMLSchema#string

clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

Radiation esophagitis-related pain, 4 weeks from the start of treatment as measured by the Numerical Rating Pain Scale for pain on swallowing (NRPS) Baseline and 4 weeks from the start of treatment [clinicaltrials_resource:737c22960adad881deeeb8a2e3b17244]

clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

Radiation esophagitis-related pain, 4 weeks from the start of treatment as measured by the Numerical Rating Pain Scale for pain on swallowing (NRPS) Baseline and 4 weeks from the start of treatment [clinicaltrials_resource:296a3a3c8e6b3625b0f8d6570d40e3cf]

Radiation esophagitis-related pain, 4 weeks from the start of treatment as measured by the Numerical Rating Pain Scale for pain on swallowing (NRPS) Baseline and 4 weeks from the start of treatment [clinicaltrials_resource:4e4f678c9ded36532a3db09478ba81cd]

Radiation esophagitis-related pain, 4 weeks from the start of treatment as measured by the Numerical Rating Pain Scale for pain on swallowing (NRPS) Baseline and 4 weeks from the start of treatment [clinicaltrials_resource:5494434d8217a4cfeebb9140fbdb2e60]

Radiation esophagitis-related pain, 4 weeks from the start of treatment as measured by the Numerical Rating Pain Scale for pain on swallowing (NRPS) Baseline and 4 weeks from the start of treatment [clinicaltrials_resource:5a43ff69833ef623e8fa5833af36ef19]

Radiation esophagitis-related pain, 4 weeks from the start of treatment as measured by the Numerical Rating Pain Scale for pain on swallowing (NRPS) Baseline and 4 weeks from the start of treatment [clinicaltrials_resource:8a76422a436bf40159b7c866abf233de]

Radiation esophagitis-related pain, 4 weeks from the start of treatment as measured by the Numerical Rating Pain Scale for pain on swallowing (NRPS) Baseline and 4 weeks from the start of treatment [clinicaltrials_resource:ab1a86448435d8ca809257fb0b328c60]

Radiation esophagitis-related pain, 4 weeks from the start of treatment as measured by the Numerical Rating Pain Scale for pain on swallowing (NRPS) Baseline and 4 weeks from the start of treatment [clinicaltrials_resource:ba19e5a850b01e44ec5520a0c1a917bd]

Radiation esophagitis-related pain, 4 weeks from the start of treatment as measured by the Numerical Rating Pain Scale for pain on swallowing (NRPS) Baseline and 4 weeks from the start of treatment [clinicaltrials_resource:d46aff3eec912ec08e3b24573c36dfa1]

Radiation esophagitis-related pain, 4 weeks from the start of treatment as measured by the Numerical Rating Pain Scale for pain on swallowing (NRPS) Baseline and 4 weeks from the start of treatment [clinicaltrials_resource:dddc9bb62518c4a4c167c6455c18a2f5]

collaborator [clinicaltrials_vocabulary:collaborator]

Radiation Therapy Oncology Group [clinicaltrials_resource:336c9b148491eaed09ba483e51b82b8d]

completion date [clinicaltrials_vocabulary:completion-date]

2014-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

detailed description [clinicaltrials_vocabulary:detailed-description]

OBJECTIVES: Prim ...... the start of study treatment.

http://www.w3.org/2001/XMLSchema#string

download date [clinicaltrials_vocabulary:download-date]

ClinicalTrials.gov processed this data on August 10, 2015

http://www.w3.org/2001/XMLSchema#string

eligibility [clinicaltrials_vocabulary:eligibility]

eligibility for clinicaltrials:NCT01262560 [clinicaltrials_resource:d1fd2b6ac87931e86d5cc3c90ec9c824]

firstreceived date [clinicaltrials_vocabulary:firstreceived-date]

2010-12-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

has expanded access [clinicaltrials_vocabulary:has-expanded-access]

No

http://www.w3.org/2001/XMLSchema#string

intervention [clinicaltrials_vocabulary:intervention]

Viscous lidocaine and magnesium aluminum oxide (Maalox®); Liquid or solid oxycodone [clinicaltrials_resource:ae8c1350510c94da4fccfa2994cbaf79]

Manuka honey [clinicaltrials_resource:ebc4678aecceb458bc89c99febc3ad0a]

intervention browse [clinicaltrials_vocabulary:intervention-browse]

Lidocaine [clinicaltrials_resource:1783543e39e61d1808f01f08b43a37d2]

Oxycodone [clinicaltrials_resource:35d9657bdde323a7585d9bf299a68e5a]

is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]

Yes

http://www.w3.org/2001/XMLSchema#string

is section 801 [clinicaltrials_vocabulary:is-section-801]

Yes

http://www.w3.org/2001/XMLSchema#string

keyword [clinicaltrials_vocabulary:keyword]

dysphagia

http://www.w3.org/2001/XMLSchema#string

esophagitis

http://www.w3.org/2001/XMLSchema#string

extensive stage small cell lung cancer

http://www.w3.org/2001/XMLSchema#string

limited stage small cell lung cancer

http://www.w3.org/2001/XMLSchema#string

pain

http://www.w3.org/2001/XMLSchema#string

recurrent non-small cell lung cancer

http://www.w3.org/2001/XMLSchema#string

recurrent small cell lung cancer

http://www.w3.org/2001/XMLSchema#string

stage IA non-small cell lung cancer

http://www.w3.org/2001/XMLSchema#string

stage IB non-small cell lung cancer

http://www.w3.org/2001/XMLSchema#string

stage IIA non-small cell lung cancer

http://www.w3.org/2001/XMLSchema#string

lastchanged date [clinicaltrials_vocabulary:lastchanged-date]

2015-03-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

lead sponsor [clinicaltrials_vocabulary:lead-sponsor]

Radiation Therapy Oncology Group [clinicaltrials_resource:336c9b148491eaed09ba483e51b82b8d]

link [clinicaltrials_vocabulary:link]

Clinical trial summary from the National Cancer Institute's PDQ® database [clinicaltrials_resource:08d385a7fc1748661ea92e82f45ad027]

location [clinicaltrials_vocabulary:location]

Providence Cancer Center at Providence Hospital [clinicaltrials_resource:d24959beab2dbc7394bc760ee47a145c]

nct id [clinicaltrials_vocabulary:nct-id]

NCT01262560

http://www.w3.org/2001/XMLSchema#string

number of arms [clinicaltrials_vocabulary:number-of-arms]

3

http://www.w3.org/2001/XMLSchema#integer

official title [clinicaltrials_vocabulary:official-title]

Phase II Randomized Trial of P ...... g the Treatment of Lung Cancer

http://www.w3.org/2001/XMLSchema#string

org study id [clinicaltrials_vocabulary:org-study-id]

RTOG 1012

http://www.w3.org/2001/XMLSchema#string

overall official [clinicaltrials_vocabulary:overall-official]

Lawrence B. Berk, MD, PhD [clinicaltrials_resource:bf0fa159efb28bb73ccf31a520aa0a64]

overall status [clinicaltrials_vocabulary:overall-status]

Completed [clinicaltrials_resource:07ca5050e697392c9ed47e6453f1453f]

oversight [clinicaltrials_vocabulary:oversight]

United States: Food and Drug Administration [clinicaltrials_resource:be4cea82cb21bbda79c939a4d720315b]

phase [clinicaltrials_vocabulary:phase]

Phase 2 [clinicaltrials_resource:56e0338b27a2d68f77402c88327b3f8d]

primary completion date [clinicaltrials_vocabulary:primary-completion-date]

2014-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

responsible party [clinicaltrials_vocabulary:responsible-party]

[clinicaltrials_resource:dbd41868ee618d3e64daa1adf8c3a8a0]

secondary id [clinicaltrials_vocabulary:secondary-id]

RTOG-1012

http://www.w3.org/2001/XMLSchema#string

source [clinicaltrials_vocabulary:source]

Radiation Therapy Oncology Group [clinicaltrials_resource:336c9b148491eaed09ba483e51b82b8d]

start date [clinicaltrials_vocabulary:start-date]

2012-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

study design [clinicaltrials_vocabulary:study-design]

clinicaltrials:NCT01262560 study design [clinicaltrials_resource:f7561a951bbcc6d8184f746bc1bab602]

study type [clinicaltrials_vocabulary:study-type]

Interventional [clinicaltrials_resource:843ac00ae5d0b7c7defb84fb42c2ce31]

url [clinicaltrials_vocabulary:url]

NCT01262560

verification date [clinicaltrials_vocabulary:verification-date]

2015-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

identifier

clinicaltrials:NCT01262560

http://www.w3.org/2001/XMLSchema#string

title

Manuka Honey in Preventing Eso ...... iation Therapy For Lung Cancer

@en